Member Info for busicat

Buying seems solid this morning

Looking more interesting here today.

Regardless of short positions, I'm thinking this is due a lift (as I see it seems to get most years from this date )...fingers crossed

Greeneyes's price v dilution comment prompted me to have a look at the numbers.

There's a handy graph of the mcap moves at https://stockanalysis.com/quote/lon/PBEE/market-cap/

The summary says that since April 21, 2021, PensionBee Group's market cap has increased from 354.65M to 375.86M, an increase of 5.98%. i.e a compound annual growth rate of 1.30%.

But as is shown, it declined from listing until Jan 2024, recovering to original levels by July 2024, since when it seems to have simply been fluctuating.

Now looks like a steady one for the future to me.

Surprised to see the number of large sales here today - hope it just means a good chance to top up while others lose patience.

"353.56k" shares traded!

353.56 shares traded according to the chart on HL at 268.49p (implying a buy) might be a good answer to the low participation doubt. Unless it's just an crossing trade. (Not shown here on lse, although around the same time, late reporting is given of the shuffling of £84.17k to and fro as at 08:25 is shown i.e.e + then - 32,43 shares .) So frustrating to not really see what's going on in a timely manner.

PBEE often publish at 16:30

Eh? NICE have not done anything to block, so why the accusations?

The ball is now in NHSE's court for logistics and is out of NICE's hands

Thanks for replying, Nissan.

Gino could only go on what he and NICE had been led to expect according to NHSE plans at that time and at that seemed likely to happen. Sadly, in the meantime, NHSE has been thrown into turmoil, with 1,000s of staff to lose their jobs and a complete reorganisation into another entity AND it has become clear there is no national funding for the version of the rollout they had envisaged.

So it doesn't surprise me that timing is now unknown (as has recently been confirmed by a NICE reply to Jimi I think it was)) for publication of roll-out guidance that for this financial year seems more academic than practical in the guise NHSE had previously expected.

Nissan, "I am expecting a huge rocket RNS for NHS England CYP2C19 news this month." - Why?

Interesting, thanks Spearks

I'm wondering if a similar exercise comparing the fate of WHSmith in the wake of their accounting error would be useful, although we don't know th outcome there yet (but can see how natural short-term price fluctuations operated).

Thank you for sharing Eureka.

Sadly further delay on this is only to be expected, given the previously confirmed absence of national budget for commissioning in the current financial year, and given the massive reorganisation and job losses involved in the process of NHS England being abolished and its functions being transferred to the Department of Health and Social Care (DHSC).

Unless I've missed it, we only know DN only crossed from under 3% to over (4.46%) on 29/7 when the price to buy was about 1.3p. Unless you believe he had no holding before or made no other purchases in the last 12 months, the highest price he has paid in the previous 12 months must be considerably higher.

DN's 8/10 posts here paint him as a long-term holder. Since he massively averaged down on the 29th of July, it seems likely he may also have done so earlier in the year at higher prices than 1.3p.

Right direction:

· FY25 revenues exceed market expectations at £6.5 million (2024: £5.8 million).

· building orders

· Year-end cash of £3.5 million (2024: £1.8 million). (following capital raise completed in H1-25)

· Full year loss before interest, tax, depreciation, and amortisation ("EBITDA") is expected to be slightly improved on market expectations at no more than a £1.6 million loss (2024: £1.7 million loss). This reflects the double-digit revenue growth offset by specific investments designed to sustain this rate of growth in future years.

Happy to take more at 252.4 : )

Thanks for confirming, Amers

Amers, am I right in thinking these are your own words you are placing in quotes here and elsewhere?

If not, whose words are they?

Sorry, Pensioninvestor, shareholders voted "no" to this

David Nuget said

"With a lot of the new posters and some of the older LTHs and even the BOD there has been calls for me to prove what finance options I bring to the company. It is not for me to finance the company or make suggestions on how I might / could / would be able to help" and the nearest he gets to proposals was

"To resurrect a funding grant that had been offered to the company but declined for no apparent reason (not from me I hasten to add)

Seek / secure new funding but by allowing our shareholders first refusal since it is evident that from the retail offering there was huge demand that had to be scaled back massively for existing LTHs with only a small amount offered to them - even though it was increased slightly."

David Nugent has already set out his ideas on this forum - see member NUG1

They don't include possible buyers or mergers